Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
Clinical trial NCT05173298 · UNKNOWN
Trial details
- NCT number
- NCT05173298
- Sponsor
- CHA University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-02
- Primary completion
- 2024-07-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.